Skip to content

Agios Pharmaceuticals AGIO Investment Purchases

Investment Purchases at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$2.51B+52.2%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$25.79M-71.1%
Precigen logo
PrecigenPGEN
$33.87M+225%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$131M
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0-100%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$52.67M

Other financials

Income statement

See full
Revenue$20.7M+138%
Gross profit$19.4M+154%
Operating income-$110.0M-3.2%
Net income-$99.1M-11.0%
EPS (diluted)-$1.69-9.0%

Balance sheet

See full
Cash & equivalents$113.6M+43.9%
Total debt$35.7M-32.5%
Total equity$1.1B-24.4%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow-$118.9M-6.7%
CapEx$769.0K+0.4%
Free cash flow-$119.7M-6.6%

Valuation

See full
Market cap$2.12B+18.1%
Enterprise value$2.04B+15.2%
P/S32.1×-16.4×

Profitability

See full
Gross margin90%+2.5pp
Operating margin-720%-204pp
Net margin-639.8%
FCF margin-582.5%-185pp

Returns & leverage

See full
Return on equity-32.8%
Debt / equity0.0×
Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agios Pharmaceuticals's investment purchases?
Agios Pharmaceuticals (AGIO) reported investment purchases of $148.18M in Q1 2026.
How has Agios Pharmaceuticals's investment purchases changed year-over-year?
Agios Pharmaceuticals's investment purchases decreased by 15.3% year-over-year, from $174.9M to $148.18M.
What is the long-term trend for Agios Pharmaceuticals's investment purchases?
Over 4 years (2021 to 2025), Agios Pharmaceuticals's investment purchases has grown at a -17.4% compound annual growth rate (CAGR), from $1.38B to $641.76M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.